Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma
- 9 Downloads
Glaucoma is the leading cause for blindness after cataracts worldwide. The aim was to identify anticholinergic drugs prescribed to patients diagnosed with closed-angle glaucoma in Colombia.
This cross-sectional study identified the prescribing patterns of cholinergic antagonists related to the increased intraocular pressure in patients diagnosed with closed-angle glaucoma from a Colombian database. The Anticholinergic Drug Scale was used to quantify the anticholinergic burden.
We identified 1958 patients with closed-angle glaucoma, with a mean age of 70.5 ± 10.3 years, 72.9% of whom were women. Cholinergic antagonists were prescribed in at least 32.4% of cases. An age range between 75 and 84 years (odds ratio (OR) 2.35, 95% confidence interval (CI) 1.366–4.059) and being aged 85 years or older (OR 3.40, 95% CI 1.809–6.425) were associated with a greater probability of receiving an anticholinergic burden between 1 and 2 points. Females (OR 1.54, 95% CI 1.096–2.181) had a higher probability of receiving an anticholinergic burden ≥ 3 points. Interactions between antiglaucoma medications and anticholinergic treatments were identified in 32.1% of the patients.
Most patients were prescribed multiple antiglaucoma medications, reflecting a large number of potentially inappropriate prescriptions, with anticholinergic drugs, related to the increased intraocular pressure.
KeywordsBlindness Cholinergic antagonists Closed-angle glaucoma Furosemide Intraocular pressure Pharmacoepidemiology
We thank Soffy Claritza López for her work in obtaining the database.
This work did not receive funding.
Compliance with ethical standards
Conflict of interests
The authors declare that they have no conflict of interest.
- 19.Chua PY, Day AC, Lai KL, et al. (2017) The incidence of acute angle closure in Scotland: a prospective surveillance study. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2017-310725. Epub ahead of print
- 24.Machado-Alba J, Hoyos-Soto V (2014) Frequency of coprescription and potential risk of bronchospasm in colombian patients users of topical antiglaucomatous betablockers and bronchodilators. Vitae 21:107–113Google Scholar